NICE considers using cancer drug to prevent blindness
The Department of Health has asked NICE to examine whether a breast cancer drug found to help prevent blindness should be available on the NHS to treat wet age-related macular degeneration.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units